6T
65 Therapeutics, Inc.
SEC filingPharmaceuticals · Somerville, MA
Amount raised$6.7Msold at filing
Total offering$6.7M
Investors in the raise2count reported to the SEC
FiledJul 6, 2026first sale Nov 21, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Murthy ChavaliDirector
Julius KnowlesExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.